Cargando…

Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by postprandial hyperglycemia, which is an early defect of T2DM and thus a primary target for anti-diabetic drugs. A therapeutic approach is to inhibit intestinal α-glucosidase, the key enzyme for dietary carbohydrate digestion, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jungbae, Jo, Sung-Hoon, Kim, Justin S., Ha, Kyoung-Soo, Lee, Jung-Yun, Choi, Hwang-Yong, Yu, Seok-Yeong, Kwon, Young-In, Kim, Young-Cheul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425110/
https://www.ncbi.nlm.nih.gov/pubmed/25906471
http://dx.doi.org/10.3390/ijms16048811
_version_ 1782370444780765184
author Oh, Jungbae
Jo, Sung-Hoon
Kim, Justin S.
Ha, Kyoung-Soo
Lee, Jung-Yun
Choi, Hwang-Yong
Yu, Seok-Yeong
Kwon, Young-In
Kim, Young-Cheul
author_facet Oh, Jungbae
Jo, Sung-Hoon
Kim, Justin S.
Ha, Kyoung-Soo
Lee, Jung-Yun
Choi, Hwang-Yong
Yu, Seok-Yeong
Kwon, Young-In
Kim, Young-Cheul
author_sort Oh, Jungbae
collection PubMed
description Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by postprandial hyperglycemia, which is an early defect of T2DM and thus a primary target for anti-diabetic drugs. A therapeutic approach is to inhibit intestinal α-glucosidase, the key enzyme for dietary carbohydrate digestion, resulting in delayed rate of glucose absorption. Although tea extracts have been reported to have anti-diabetic effects, the potential bioactivity of tea pomace, the main bio waste of tea beverage processing, is largely unknown. We evaluated the anti-diabetic effects of three selected tea water extracts (TWE) and tea pomace extracts (TPE) by determining the relative potency of extracts on rat intestinal α-glucosidase activity in vitro as well as hypoglycemic effects in vivo. Green, oolong, and black tea bags were extracted in hot water and the remaining tea pomace were dried and further extracted in 70% ethanol. The extracts were determined for intestinal rat α-glucosidases activity, radical scavenging activity, and total phenolic content. The postprandial glucose-lowering effects of TWE and TPE of green and black tea were assessed in male Sprague-Dawley (SD) rats and compared to acarbose, a known pharmacological α-glucosidase inhibitor. The IC(50) values of all three tea extracts against mammalian α-glucosidase were lower or similar in TPE groups than those of TWE groups. TWE and TPE of green tea exhibited the highest inhibitory effects against α-glucosidase activity with the IC(50) of 2.04 ± 0.31 and 1.95 ± 0.37 mg/mL respectively. Among the specific enzymes tested, the IC(50) values for TWE (0.16 ± 0.01 mg/mL) and TPE (0.13 ± 0.01 mg/mL) of green tea against sucrase activity were the lowest compared to those on maltase and glucoamylase activities. In the animal study, the blood glucose level at 30 min after oral intake (0.5 g/kg body wt) of TPE and TWE of both green and black tea was significantly reduced compared to the control in sucrose-loaded SD rats. The TPE of all three teas had significantly higher phenolic content than those of the TWE groups, which correlated strongly with the DPPH radical scavenging activity. This is the first report of tea pomace extract significantly inhibits intestinal α-glucosidase, resulting in delayed glucose absorption and thereby suppressed postprandial hyperglycemia. Our data suggest that tea pomace-derived bioactives may have great potential for further development as nutraceutical products and the reuse of otherwise biowaste as valuable bioresources for the industry.
format Online
Article
Text
id pubmed-4425110
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44251102015-05-20 Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo Oh, Jungbae Jo, Sung-Hoon Kim, Justin S. Ha, Kyoung-Soo Lee, Jung-Yun Choi, Hwang-Yong Yu, Seok-Yeong Kwon, Young-In Kim, Young-Cheul Int J Mol Sci Article Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by postprandial hyperglycemia, which is an early defect of T2DM and thus a primary target for anti-diabetic drugs. A therapeutic approach is to inhibit intestinal α-glucosidase, the key enzyme for dietary carbohydrate digestion, resulting in delayed rate of glucose absorption. Although tea extracts have been reported to have anti-diabetic effects, the potential bioactivity of tea pomace, the main bio waste of tea beverage processing, is largely unknown. We evaluated the anti-diabetic effects of three selected tea water extracts (TWE) and tea pomace extracts (TPE) by determining the relative potency of extracts on rat intestinal α-glucosidase activity in vitro as well as hypoglycemic effects in vivo. Green, oolong, and black tea bags were extracted in hot water and the remaining tea pomace were dried and further extracted in 70% ethanol. The extracts were determined for intestinal rat α-glucosidases activity, radical scavenging activity, and total phenolic content. The postprandial glucose-lowering effects of TWE and TPE of green and black tea were assessed in male Sprague-Dawley (SD) rats and compared to acarbose, a known pharmacological α-glucosidase inhibitor. The IC(50) values of all three tea extracts against mammalian α-glucosidase were lower or similar in TPE groups than those of TWE groups. TWE and TPE of green tea exhibited the highest inhibitory effects against α-glucosidase activity with the IC(50) of 2.04 ± 0.31 and 1.95 ± 0.37 mg/mL respectively. Among the specific enzymes tested, the IC(50) values for TWE (0.16 ± 0.01 mg/mL) and TPE (0.13 ± 0.01 mg/mL) of green tea against sucrase activity were the lowest compared to those on maltase and glucoamylase activities. In the animal study, the blood glucose level at 30 min after oral intake (0.5 g/kg body wt) of TPE and TWE of both green and black tea was significantly reduced compared to the control in sucrose-loaded SD rats. The TPE of all three teas had significantly higher phenolic content than those of the TWE groups, which correlated strongly with the DPPH radical scavenging activity. This is the first report of tea pomace extract significantly inhibits intestinal α-glucosidase, resulting in delayed glucose absorption and thereby suppressed postprandial hyperglycemia. Our data suggest that tea pomace-derived bioactives may have great potential for further development as nutraceutical products and the reuse of otherwise biowaste as valuable bioresources for the industry. MDPI 2015-04-21 /pmc/articles/PMC4425110/ /pubmed/25906471 http://dx.doi.org/10.3390/ijms16048811 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Oh, Jungbae
Jo, Sung-Hoon
Kim, Justin S.
Ha, Kyoung-Soo
Lee, Jung-Yun
Choi, Hwang-Yong
Yu, Seok-Yeong
Kwon, Young-In
Kim, Young-Cheul
Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo
title Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo
title_full Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo
title_fullStr Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo
title_full_unstemmed Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo
title_short Selected Tea and Tea Pomace Extracts Inhibit Intestinal α-Glucosidase Activity in Vitro and Postprandial Hyperglycemia in Vivo
title_sort selected tea and tea pomace extracts inhibit intestinal α-glucosidase activity in vitro and postprandial hyperglycemia in vivo
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425110/
https://www.ncbi.nlm.nih.gov/pubmed/25906471
http://dx.doi.org/10.3390/ijms16048811
work_keys_str_mv AT ohjungbae selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT josunghoon selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT kimjustins selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT hakyoungsoo selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT leejungyun selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT choihwangyong selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT yuseokyeong selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT kwonyoungin selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo
AT kimyoungcheul selectedteaandteapomaceextractsinhibitintestinalaglucosidaseactivityinvitroandpostprandialhyperglycemiainvivo